1. Home
  2. MDAI vs NEPH Comparison

MDAI vs NEPH Comparison

Compare MDAI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • NEPH
  • Stock Information
  • Founded
  • MDAI 2013
  • NEPH 1997
  • Country
  • MDAI United States
  • NEPH United States
  • Employees
  • MDAI N/A
  • NEPH N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • NEPH Medical/Dental Instruments
  • Sector
  • MDAI Health Care
  • NEPH Health Care
  • Exchange
  • MDAI Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • MDAI 51.9M
  • NEPH 57.2M
  • IPO Year
  • MDAI N/A
  • NEPH 2004
  • Fundamental
  • Price
  • MDAI $2.13
  • NEPH $5.70
  • Analyst Decision
  • MDAI Strong Buy
  • NEPH Strong Buy
  • Analyst Count
  • MDAI 1
  • NEPH 2
  • Target Price
  • MDAI $3.50
  • NEPH $5.50
  • AVG Volume (30 Days)
  • MDAI 868.8K
  • NEPH 87.4K
  • Earning Date
  • MDAI 11-11-2025
  • NEPH 11-06-2025
  • Dividend Yield
  • MDAI N/A
  • NEPH N/A
  • EPS Growth
  • MDAI N/A
  • NEPH N/A
  • EPS
  • MDAI N/A
  • NEPH 0.12
  • Revenue
  • MDAI $27,549,000.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • MDAI N/A
  • NEPH $24.38
  • Revenue Next Year
  • MDAI $60.05
  • NEPH $10.16
  • P/E Ratio
  • MDAI N/A
  • NEPH $47.83
  • Revenue Growth
  • MDAI 22.27
  • NEPH 21.16
  • 52 Week Low
  • MDAI $1.01
  • NEPH $1.39
  • 52 Week High
  • MDAI $3.25
  • NEPH $5.98
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 44.61
  • NEPH 60.60
  • Support Level
  • MDAI $2.07
  • NEPH $4.86
  • Resistance Level
  • MDAI $2.27
  • NEPH $5.97
  • Average True Range (ATR)
  • MDAI 0.19
  • NEPH 0.49
  • MACD
  • MDAI -0.04
  • NEPH 0.01
  • Stochastic Oscillator
  • MDAI 7.61
  • NEPH 81.38

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: